Observe Medical ASA

With Sippi, the company’s prevalent current focus is on addressing the challenge of hospital acquired infection in healthcare facilities worldwide. Urinary tract infections are the number one hospital acquired complication for patients, and their treatment is a considerable burden to hospital staff and budgets. Overall, almost 3 million Europeans are infected every year from hospital acquired infections of all types.

Observe Medical’s intent is to continually grow their platform and portfolio to address these and other healthcare challenges, through ongoing R&D and acquisition strategies in line with our their goals and vision.

In 2022, the Company acquired 100% of the shares in Biim Ultrasound, which has developed a unique, wireless and pocketable ultrasound probe, Biim, that can scan patients and review images in seconds.

The Company is listed on Oslo Axess and is headquartered in Oslo, Norway, with operational activities in Stockholm and Gothenburg, Sweden.